# Rallybio (RLYB) — Earnings

RLYB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rlyb/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$1.76 |
| EPS estimate | −$1.96 |
| EPS surprise | +10.20% |
| Revenue surprise | +0.00% |
| Revenue | $212,000.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 7, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1739410/000173941025000112/rlyb-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 7, 2025 | −$1.96 | −$1.76 | 10.20% | — | $212,000.00 |
| Q1 2025 | May 8, 2025 | −$2.08 | −$1.68 | 19.23% | — | $212,000.00 |
| Q4 2024 | Mar 13, 2025 | −$2.30 | −$2.00 | 13.04% | $149,500.00 | $38,000.00 |
| Q3 2024 | Nov 7, 2024 | −$2.82 | −$2.08 | 26.14% | $75,000.00 | $299,000.00 |
| Q2 2024 | Aug 8, 2024 | −$2.99 | −$2.96 | 1.15% | — | $299,000.00 |
| Q1 2024 | May 9, 2024 | −$3.79 | −$3.76 | 0.72% | — | — |
| Q4 2023 | Mar 12, 2024 | −$3.59 | −$4.00 | -11.45% | — | — |
| Q3 2023 | Nov 9, 2023 | −$4.07 | −$3.60 | 11.55% | — | — |
| Q2 2023 | Aug 8, 2023 | −$3.83 | −$3.68 | 3.96% | — | — |
| Q1 2023 | May 9, 2023 | −$3.88 | −$3.44 | 11.41% | — | — |
| Q4 2022 | Mar 6, 2023 | −$4.77 | −$3.68 | 22.82% | — | — |
| Q3 2022 | Nov 7, 2022 | −$4.34 | −$4.80 | -10.60% | — | — |
| Q2 2022 | Aug 8, 2022 | −$4.76 | −$4.56 | 4.20% | — | — |
| Q1 2022 | May 10, 2022 | −$3.62 | −$3.84 | -6.08% | — | — |
| Q4 2021 | Mar 15, 2022 | −$3.12 | −$3.36 | -7.69% | — | — |
| Q3 2021 | Nov 10, 2021 | −$7.08 | −$2.96 | 58.19% | — | — |
| Q2 2021 | Sep 9, 2021 | −$34.44 | −$22.40 | 34.96% | — | — |

## Frequently Asked Questions

### When did Rallybio (RLYB) last report earnings?

Rallybio last reported on Aug 7, 2025, covering fiscal Q2 2025.

### Did RLYB beat earnings estimates?

Yes. Rallybio reported EPS of −$1.76 for Q2 2025 against a −$1.96 estimate — a 10.20% beat.

### How much revenue did RLYB report last quarter?

Rallybio reported $212,000.00 in revenue for Q2 2025.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).